» Articles » PMID: 38334676

Imeglimin Exhibits Novel Anti-Inflammatory Effects on High-Glucose-Stimulated Mouse Microglia Through ULK1-Mediated Suppression of the TXNIP-NLRP3 Axis

Overview
Journal Cells
Publisher MDPI
Date 2024 Feb 9
PMID 38334676
Authors
Affiliations
Soon will be listed here.
Abstract

Type 2 diabetes mellitus (T2DM) is an epidemiological risk factor for dementia and has been implicated in multifactorial pathologies, including neuroinflammation. In the present study, we aimed to elucidate the potential anti-inflammatory effects of imeglimin, a novel antidiabetic agent, on high-glucose (HG)-stimulated microglia. Mouse microglial BV2 cells were stimulated with HG in the presence or absence of imeglimin. We examined the effects of imeglimin on the levels of proinflammatory cytokines, intracellular reactive oxygen species (ROS), mitochondrial integrity, and components related to the inflammasome or autophagy pathways in these cells. Our results showed that imeglimin suppressed the HG-induced production of interleukin-1beta (IL-1β) by reducing the intracellular ROS levels, ameliorating mitochondrial dysfunction, and inhibiting the activation of the thioredoxin-interacting protein (TXNIP)-NOD-like receptor family pyrin domain containing 3 (NLRP3) axis. Moreover, the inhibitory effects of imeglimin on the TXNIP-NLRP3 axis depended on the imeglimin-induced activation of ULK1, which also exhibited novel anti-inflammatory effects without autophagy induction. These findings suggest that imeglimin exerted novel suppressive effects on HG-stimulated microglia through the ULK1-TXNIP-NLRP3 axis, and may, thereby, contribute to the development of innovative strategies to prevent T2DM-associated cognitive impairment.

Citing Articles

Gut-Brain Axis: Focus on Sex Differences in Neuroinflammation.

Caldarelli M, Rio P, Marrone A, Ocarino F, Chiantore M, Candelli M Int J Mol Sci. 2024; 25(10).

PMID: 38791415 PMC: 11120930. DOI: 10.3390/ijms25105377.

References
1.
Li Y, Long W, Gao M, Jiao F, Chen Z, Liu M . TREM2 Regulates High Glucose-Induced Microglial Inflammation via the NLRP3 Signaling Pathway. Brain Sci. 2021; 11(7). PMC: 8306970. DOI: 10.3390/brainsci11070896. View

2.
Ohara T, Doi Y, Ninomiya T, Hirakawa Y, Hata J, Iwaki T . Glucose tolerance status and risk of dementia in the community: the Hisayama study. Neurology. 2011; 77(12):1126-34. DOI: 10.1212/WNL.0b013e31822f0435. View

3.
Wu J, Yang Y, Liu L, Zhu W, Liu M, Yu X . ROS-AMPK/mTOR-dependent enterocyte autophagy is involved in the regulation of infection-related tight junction protein and nitric oxide levels. Front Immunol. 2023; 14:1120996. PMC: 10043474. DOI: 10.3389/fimmu.2023.1120996. View

4.
Plaza-Zabala A, Sierra-Torre V, Sierra A . Assessing Autophagy in Microglia: A Two-Step Model to Determine Autophagosome Formation, Degradation, and Net Turnover. Front Immunol. 2021; 11:620602. PMC: 7878397. DOI: 10.3389/fimmu.2020.620602. View

5.
Detaille D, Vial G, Borel A, Cottet-Rouselle C, Hallakou-Bozec S, Bolze S . Imeglimin prevents human endothelial cell death by inhibiting mitochondrial permeability transition without inhibiting mitochondrial respiration. Cell Death Discov. 2016; 2:15072. PMC: 4979505. DOI: 10.1038/cddiscovery.2015.72. View